Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05NYO
|
|||
| Former ID |
DIB016358
|
|||
| Drug Name |
Imab-027
|
|||
| Synonyms |
IMAB-512 series; Anti-GT512 mAbs (cancer), Ganymed; Anti-GT512 monoclonal antibodies (cancer), Ganymed
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1/2 | [1] | |
| Company |
Ganymed Pharmaceuticals AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02054351) Phase 1/2 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.